October 26, 2010

HIV Negative Adults Between Age 18-50 Needed for an HIV Vaccine Trial

In the United States, HIV disproportionately infects certain groups and populations. However, HIV can infect anyone.
Worldwide there are currently more than 40 million people infected with HIV. That number is growing.

Developing a vaccine is our best hope to control HIV/AIDS.
The Vanderbilt HIV Vaccine Program needs healthy, uninfected adults (age 18-50) from all walks of life to help find a vaccine to prevent HIV infection.

There is no risk of HIV infection from the vaccines.
Volunteers must be available locally for 12-18 months. Volunteers will be compensated.

Call 322-HOPE (322-4673) or e-mail casey.h.braddy@vanderbilt.edu for more information.

You can help fight the HIV/AIDS epidemic. In order to develop a vaccine that will work for everyone, we need help from everyone.

All racial and ethnic groups are encouraged to contact our program.